A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer

Development of metastases to central nervous system (CNS) is an increasing clinical issue following the diagnosis of advanced breast cancer. The propensity to metastasize to CNS varies by breast cancer subtype. Of the four breast cancer subtypes, triple-negative breast cancers (TNBC) have the highes...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jiaojiao, Chernikova, Sophia B., Wang, Yuelong, Rodriguez, Mirna L., Andersen, Stephanie J., Umeh-Garcia, Maxine C., Godfrey, Bryanna O., Ahmadian, Saman S., Fischer, Wolf-Nicolas, Koller, Kerry J., Jandeleit, Bernd, Ringold, Gordon M., Gephart, Melanie Hayden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
MCT First Disclosures
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571036/
https://www.ncbi.nlm.nih.gov/pubmed/34635566
http://dx.doi.org/10.1158/1535-7163.MCT-21-0140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571036/
https://www.ncbi.nlm.nih.gov/pubmed/34635566
http://dx.doi.org/10.1158/1535-7163.MCT-21-0140

Ejemplares similares